Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

62.70 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytokinetics, Incorporated - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst ↗

January 12, 2024

Novartis halts pursuit of Cytokinetics acquisition, impacting promising heart drug. Analysts estimate $3.6 billion sales for Cytokinetics' cardiomyopathy drug by 2032. Still lead drug aficamten viewed...

Via Benzinga

Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition ↗

January 11, 2024

Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow to the potential deal with the

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 11, 2024

Via Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday ↗

January 11, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...

Via Benzinga

Topics Stocks

2 Biotechs That Could Get Bought Out in 2024 ↗

January 03, 2024

These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.

Via The Motley Fool

Cytokinetics Inc. (NASDAQ: CYTK) Leading the Way in Thursday Trading Based on Percentage Gain

December 21, 2023

Via Investor Brand Network

Bullish Continuation In '24? 3 Market Areas To Watch ↗

January 10, 2024

This article discusses 3 market areas that should outperform dramatically over the next 12 months...

Via Talk Markets

What's Been Happening With Cytokinetics Stock? ↗

January 09, 2024

Cytokinetics, Incorporated (NASDAQ: CYTK) shares are trading lower on Tuesday, pulling back from Monday strength.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today? ↗

January 08, 2024

Cytokinetics Inc (NASDAQ: CYTK) shares are trading higher after a report on potential takeover talks with Novartis AG (NYSE: NVS).

Via Benzinga

Cytokinetics Rockets 14% As Novartis Reportedly Nears A Buyout Deal ↗

January 08, 2024

The company is working on a treatment for a disease that can lead to heart failure.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 08, 2024

Via Benzinga

CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday ↗

January 05, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2024

Via Benzinga

7 Stocks Primed for a Spectacular Comeback in 2024 ↗

January 03, 2024

Although the usual suspects may carry confidence, these underappreciated comeback stocks might deliver the goods in 2024.

Via InvestorPlace

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 29, 2023

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study ↗

December 28, 2023

On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before.

Via Investor's Business Daily

Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch ↗

December 28, 2023

On Wednesday, Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy...

Via Benzinga

Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗

December 28, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher ↗

December 27, 2023

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...

Via Benzinga

Topics Stocks

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 27, 2023

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...

Via Benzinga

Why Is Cytokinetics (CYTK) Stock Up 70% Today? ↗

December 27, 2023

With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

Stocks Static As Post-Holiday Doldrums Hit ↗

December 27, 2023

Stocks are struggling for direction today, as the post-holiday doldrums take full effect.

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 27, 2023

Via Benzinga

Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December ↗

December 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...

Via Benzinga

Topics Economy Stocks

Why Is Heart Disease Focused Cytokinetics Stock Trading Higher Today? ↗

December 27, 2023

Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 27, 2023

Via Benzinga

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 14, 2023

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.